Previously, it has been predicted SMR3B has GATA3 transcription factor binding site motif41 and is expressed more in triple-negative breast cancer patients with poor prognosis compared to the low-risk patients42. The gene discussed is SMR3B; the disease is triple-negative breast carcinoma.